Executive Intelligence

Andrew Beck

Founder

Andrew Beck is listed as a founder of PathAI based in United States on Brel Digital’s verified company intelligence record.

In this profile

Quick Facts

  • Role Founder
  • Company PathAI
  • Country United States
  • Industry AI in Healthcare
  • Founded 2016
  • Known For PathAI is a central case study in digital pathology consolidation: its announced merger agreement with Roche…
  • Status Active
  • Last Reviewed Jul 2026

Executive Summary

Andrew Beck appears in Brel Digital’s verified company_founders attribution for PathAI based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted. Company context (from the verified PathAI profile): Boston digital pathology company applying AI to tissue analysis, with a announced Roche merger agreement pending close Why the company matters (verified company field): PathAI is a central case study in digital pathology consolidation: its announced merger agreement with Roche — disclosed but not yet closed as of this review — shows how diagnostic giants are buying AI pathology capability rather than building it entirely from scratch. Official company website on file: https://www.pathai.com. Readers should consult that site and the Sources section for primary evidence. Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Career Timeline

Verified company milestones linked to this executive’s organization.

  1. 2016 Company founded

    PathAI was founded in 2016 per the company profile source on file.

    Source
  2. 2016 Development

    2016: PathAI founded in Boston by Andrew Beck.

    Source
  3. 2026 Acquisition

    May 7, 2026: Roche announced a definitive merger agreement to acquire PathAI, with $750 million upfront consideration; the transaction had not closed as of this review.

    Source

Connected Company

Connected Products

Connected Reports

Connected Insights

Industry Intelligence

Andrew Beck appears in Brel Digital’s verified company_founders attribution for PathAI based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.

Company context (from the verified PathAI profile): Boston digital pathology company applying AI to tissue analysis, with a announced Roche merger agreement pending close

Why the company matters (verified company field): PathAI is a central case study in digital pathology consolidation: its announced merger agreement with Roche — disclosed but not yet closed as of this review — shows how diagnostic giants are buying AI pathology capability rather than building it entirely from scratch.

Official company website on file: https://www.pathai.com. Readers should consult that site and the Sources section for primary evidence.

Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

The AI Brief

Founder and company intelligence, weekly.

Subscribe